(Q48897086)

16 February 2018

title

Effect of neuroleptic treatment on polysomnographic measures in schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

28 October 2022

0 references

1

S. F. Taylor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684117

28 October 2022

author name string

R. Tandon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684117

28 October 2022

J. E. Shipley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684117

28 October 2022

A. S. Eiser

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1684117

28 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

16 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0006322391900046?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

https://api.elsevier.com/content/article/PII:0006322391900046?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

28 October 2022

published in

Biological Psychiatry

1 reference

16 February 2018

volume

30

1 reference

16 February 2018

issue

9

1 reference

16 February 2018

page(s)

904-912

1 reference

16 February 2018

Mesoridazine and human sleep

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Pimozide attentuates d-amphetamine-induced sleep changes in man

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

The sleep of patients with obsessive-compulsive disorder.

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Digital computer analyzed sleep and resting EEG during haloperidol treatment

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics.

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Electroencephalographic sleep in schizophrenia: a critical review

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Two roads to rapid eye movement latency

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Sleep disturbance in acute schizophrenic patients

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

EEG sleep in outpatients with generalized anxiety: a preliminary comparison with depressed outpatients.

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Effects of central dopaminergic blockade with pimozide upon the EEG stages of sleep in man

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90004-6

28 October 2022

Identifiers

1 reference

16 February 2018

1 reference

16 February 2018